[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global PCR and Real-time PCR Molecular Diagnostics Market Growth (Status and Outlook) 2024-2030

June 2024 | 109 pages | ID: GDFB0AD3F493EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The report requires updating with new data and is sent in 48 hours after order is placed.

According to our LPI (LP Information) latest study, the global PCR and Real-time PCR Molecular Diagnostics market size was valued at US$ million in 2023. With growing demand in downstream market, the PCR and Real-time PCR Molecular Diagnostics is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period.

The research report highlights the growth potential of the global PCR and Real-time PCR Molecular Diagnostics market. PCR and Real-time PCR Molecular Diagnostics are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of PCR and Real-time PCR Molecular Diagnostics. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the PCR and Real-time PCR Molecular Diagnostics market.

Real-time PCR Molecular Diagnostics has high sensitivity, higher accuracy and less pollution, and can process test results in a timely manner, thus limiting the error range.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Key Features:

The report on PCR and Real-time PCR Molecular Diagnostics market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the PCR and Real-time PCR Molecular Diagnostics market. It may include historical data, market segmentation by Type (e.g., Instruments, Reagents), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the PCR and Real-time PCR Molecular Diagnostics market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the PCR and Real-time PCR Molecular Diagnostics market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the PCR and Real-time PCR Molecular Diagnostics industry. This include advancements in PCR and Real-time PCR Molecular Diagnostics technology, PCR and Real-time PCR Molecular Diagnostics new entrants, PCR and Real-time PCR Molecular Diagnostics new investment, and other innovations that are shaping the future of PCR and Real-time PCR Molecular Diagnostics.

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the PCR and Real-time PCR Molecular Diagnostics market. It includes factors influencing customer ' purchasing decisions, preferences for PCR and Real-time PCR Molecular Diagnostics product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the PCR and Real-time PCR Molecular Diagnostics market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting PCR and Real-time PCR Molecular Diagnostics market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the PCR and Real-time PCR Molecular Diagnostics market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the PCR and Real-time PCR Molecular Diagnostics industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the PCR and Real-time PCR Molecular Diagnostics market.

Market Segmentation:

PCR and Real-time PCR Molecular Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
  • Instruments
  • Reagents
  • Consumables
Segmentation by application
  • Infectious Diseases Testing
  • Oncology Testing
  • Genetic Testing
  • Others
This report also splits the market by region:
  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
  • Abbott Laboratories
  • bioMereieux SA
  • Danaher Corporation
  • Bio-Rad Laboratories
  • QIAGEN N.V
  • F-Hoffmann-La Roche Ltd.
  • Genomic Health
  • GRIFOLS S.A
  • Thermo Fisher Scientific Inc.
  • Seegene Inc.
  • Hologic Inc.
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global PCR and Real-time PCR Molecular Diagnostics Market Size 2019-2030
  2.1.2 PCR and Real-time PCR Molecular Diagnostics Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 PCR and Real-time PCR Molecular Diagnostics Segment by Type
  2.2.1 Instruments
  2.2.2 Reagents
  2.2.3 Consumables
2.3 PCR and Real-time PCR Molecular Diagnostics Market Size by Type
  2.3.1 PCR and Real-time PCR Molecular Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030)
  2.3.2 Global PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Type (2019-2024)
2.4 PCR and Real-time PCR Molecular Diagnostics Segment by Application
  2.4.1 Infectious Diseases Testing
  2.4.2 Oncology Testing
  2.4.3 Genetic Testing
  2.4.4 Others
2.5 PCR and Real-time PCR Molecular Diagnostics Market Size by Application
  2.5.1 PCR and Real-time PCR Molecular Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030)
  2.5.2 Global PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Application (2019-2024)

3 PCR AND REAL-TIME PCR MOLECULAR DIAGNOSTICS MARKET SIZE BY PLAYER

3.1 PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Players
  3.1.1 Global PCR and Real-time PCR Molecular Diagnostics Revenue by Players (2019-2024)
  3.1.2 Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Players (2019-2024)
3.2 Global PCR and Real-time PCR Molecular Diagnostics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 PCR AND REAL-TIME PCR MOLECULAR DIAGNOSTICS BY REGIONS

4.1 PCR and Real-time PCR Molecular Diagnostics Market Size by Regions (2019-2024)
4.2 Americas PCR and Real-time PCR Molecular Diagnostics Market Size Growth (2019-2024)
4.3 APAC PCR and Real-time PCR Molecular Diagnostics Market Size Growth (2019-2024)
4.4 Europe PCR and Real-time PCR Molecular Diagnostics Market Size Growth (2019-2024)
4.5 Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size Growth (2019-2024)

5 AMERICAS

5.1 Americas PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2019-2024)
5.2 Americas PCR and Real-time PCR Molecular Diagnostics Market Size by Type (2019-2024)
5.3 Americas PCR and Real-time PCR Molecular Diagnostics Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC PCR and Real-time PCR Molecular Diagnostics Market Size by Region (2019-2024)
6.2 APAC PCR and Real-time PCR Molecular Diagnostics Market Size by Type (2019-2024)
6.3 APAC PCR and Real-time PCR Molecular Diagnostics Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe PCR and Real-time PCR Molecular Diagnostics by Country (2019-2024)
7.2 Europe PCR and Real-time PCR Molecular Diagnostics Market Size by Type (2019-2024)
7.3 Europe PCR and Real-time PCR Molecular Diagnostics Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa PCR and Real-time PCR Molecular Diagnostics by Region (2019-2024)
8.2 Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size by Type (2019-2024)
8.3 Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL PCR AND REAL-TIME PCR MOLECULAR DIAGNOSTICS MARKET FORECAST

10.1 Global PCR and Real-time PCR Molecular Diagnostics Forecast by Regions (2025-2030)
  10.1.1 Global PCR and Real-time PCR Molecular Diagnostics Forecast by Regions (2025-2030)
  10.1.2 Americas PCR and Real-time PCR Molecular Diagnostics Forecast
  10.1.3 APAC PCR and Real-time PCR Molecular Diagnostics Forecast
  10.1.4 Europe PCR and Real-time PCR Molecular Diagnostics Forecast
  10.1.5 Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Forecast
10.2 Americas PCR and Real-time PCR Molecular Diagnostics Forecast by Country (2025-2030)
  10.2.1 United States PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.2.2 Canada PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.2.3 Mexico PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.2.4 Brazil PCR and Real-time PCR Molecular Diagnostics Market Forecast
10.3 APAC PCR and Real-time PCR Molecular Diagnostics Forecast by Region (2025-2030)
  10.3.1 China PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.3.2 Japan PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.3.3 Korea PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.3.4 Southeast Asia PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.3.5 India PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.3.6 Australia PCR and Real-time PCR Molecular Diagnostics Market Forecast
10.4 Europe PCR and Real-time PCR Molecular Diagnostics Forecast by Country (2025-2030)
  10.4.1 Germany PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.4.2 France PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.4.3 UK PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.4.4 Italy PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.4.5 Russia PCR and Real-time PCR Molecular Diagnostics Market Forecast
10.5 Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Forecast by Region (2025-2030)
  10.5.1 Egypt PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.5.2 South Africa PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.5.3 Israel PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.5.4 Turkey PCR and Real-time PCR Molecular Diagnostics Market Forecast
  10.5.5 GCC Countries PCR and Real-time PCR Molecular Diagnostics Market Forecast
10.6 Global PCR and Real-time PCR Molecular Diagnostics Forecast by Type (2025-2030)
10.7 Global PCR and Real-time PCR Molecular Diagnostics Forecast by Application (2025-2030)

11 KEY PLAYERS ANALYSIS

11.1 Abbott Laboratories
  11.1.1 Abbott Laboratories Company Information
  11.1.2 Abbott Laboratories PCR and Real-time PCR Molecular Diagnostics Product Offered
  11.1.3 Abbott Laboratories PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.1.4 Abbott Laboratories Main Business Overview
  11.1.5 Abbott Laboratories Latest Developments
11.2 bioMereieux SA
  11.2.1 bioMereieux SA Company Information
  11.2.2 bioMereieux SA PCR and Real-time PCR Molecular Diagnostics Product Offered
  11.2.3 bioMereieux SA PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.2.4 bioMereieux SA Main Business Overview
  11.2.5 bioMereieux SA Latest Developments
11.3 Danaher Corporation
  11.3.1 Danaher Corporation Company Information
  11.3.2 Danaher Corporation PCR and Real-time PCR Molecular Diagnostics Product Offered
  11.3.3 Danaher Corporation PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.3.4 Danaher Corporation Main Business Overview
  11.3.5 Danaher Corporation Latest Developments
11.4 Bio-Rad Laboratories
  11.4.1 Bio-Rad Laboratories Company Information
  11.4.2 Bio-Rad Laboratories PCR and Real-time PCR Molecular Diagnostics Product Offered
  11.4.3 Bio-Rad Laboratories PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.4.4 Bio-Rad Laboratories Main Business Overview
  11.4.5 Bio-Rad Laboratories Latest Developments
11.5 QIAGEN N.V
  11.5.1 QIAGEN N.V Company Information
  11.5.2 QIAGEN N.V PCR and Real-time PCR Molecular Diagnostics Product Offered
  11.5.3 QIAGEN N.V PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.5.4 QIAGEN N.V Main Business Overview
  11.5.5 QIAGEN N.V Latest Developments
11.6 F-Hoffmann-La Roche Ltd.
  11.6.1 F-Hoffmann-La Roche Ltd. Company Information
  11.6.2 F-Hoffmann-La Roche Ltd. PCR and Real-time PCR Molecular Diagnostics Product Offered
  11.6.3 F-Hoffmann-La Roche Ltd. PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.6.4 F-Hoffmann-La Roche Ltd. Main Business Overview
  11.6.5 F-Hoffmann-La Roche Ltd. Latest Developments
11.7 Genomic Health
  11.7.1 Genomic Health Company Information
  11.7.2 Genomic Health PCR and Real-time PCR Molecular Diagnostics Product Offered
  11.7.3 Genomic Health PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.7.4 Genomic Health Main Business Overview
  11.7.5 Genomic Health Latest Developments
11.8 GRIFOLS S.A
  11.8.1 GRIFOLS S.A Company Information
  11.8.2 GRIFOLS S.A PCR and Real-time PCR Molecular Diagnostics Product Offered
  11.8.3 GRIFOLS S.A PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.8.4 GRIFOLS S.A Main Business Overview
  11.8.5 GRIFOLS S.A Latest Developments
11.9 Thermo Fisher Scientific Inc.
  11.9.1 Thermo Fisher Scientific Inc. Company Information
  11.9.2 Thermo Fisher Scientific Inc. PCR and Real-time PCR Molecular Diagnostics Product Offered
  11.9.3 Thermo Fisher Scientific Inc. PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.9.4 Thermo Fisher Scientific Inc. Main Business Overview
  11.9.5 Thermo Fisher Scientific Inc. Latest Developments
11.10 Seegene Inc.
  11.10.1 Seegene Inc. Company Information
  11.10.2 Seegene Inc. PCR and Real-time PCR Molecular Diagnostics Product Offered
  11.10.3 Seegene Inc. PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.10.4 Seegene Inc. Main Business Overview
  11.10.5 Seegene Inc. Latest Developments
11.11 Hologic Inc.
  11.11.1 Hologic Inc. Company Information
  11.11.2 Hologic Inc. PCR and Real-time PCR Molecular Diagnostics Product Offered
  11.11.3 Hologic Inc. PCR and Real-time PCR Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
  11.11.4 Hologic Inc. Main Business Overview
  11.11.5 Hologic Inc. Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION


LIST OF TABLES

Table 1. PCR and Real-time PCR Molecular Diagnostics Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Instruments
Table 3. Major Players of Reagents
Table 4. Major Players of Consumables
Table 5. PCR and Real-time PCR Molecular Diagnostics Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 6. Global PCR and Real-time PCR Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 7. Global PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 8. PCR and Real-time PCR Molecular Diagnostics Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 9. Global PCR and Real-time PCR Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 10. Global PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 11. Global PCR and Real-time PCR Molecular Diagnostics Revenue by Players (2019-2024) & ($ Millions)
Table 12. Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Player (2019-2024)
Table 13. PCR and Real-time PCR Molecular Diagnostics Key Players Head office and Products Offered
Table 14. PCR and Real-time PCR Molecular Diagnostics Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global PCR and Real-time PCR Molecular Diagnostics Market Size by Regions 2019-2024 & ($ Millions)
Table 18. Global PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Regions (2019-2024)
Table 19. Global PCR and Real-time PCR Molecular Diagnostics Revenue by Country/Region (2019-2024) & ($ millions)
Table 20. Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Country/Region (2019-2024)
Table 21. Americas PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 22. Americas PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Country (2019-2024)
Table 23. Americas PCR and Real-time PCR Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 24. Americas PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 25. Americas PCR and Real-time PCR Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 26. Americas PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 27. APAC PCR and Real-time PCR Molecular Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 28. APAC PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Region (2019-2024)
Table 29. APAC PCR and Real-time PCR Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 30. APAC PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 31. APAC PCR and Real-time PCR Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 32. APAC PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 33. Europe PCR and Real-time PCR Molecular Diagnostics Market Size by Country (2019-2024) & ($ Millions)
Table 34. Europe PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Country (2019-2024)
Table 35. Europe PCR and Real-time PCR Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 36. Europe PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 37. Europe PCR and Real-time PCR Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 38. Europe PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 39. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size by Region (2019-2024) & ($ Millions)
Table 40. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Region (2019-2024)
Table 41. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size by Type (2019-2024) & ($ Millions)
Table 42. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Table 43. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size by Application (2019-2024) & ($ Millions)
Table 44. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Table 45. Key Market Drivers & Growth Opportunities of PCR and Real-time PCR Molecular Diagnostics
Table 46. Key Market Challenges & Risks of PCR and Real-time PCR Molecular Diagnostics
Table 47. Key Industry Trends of PCR and Real-time PCR Molecular Diagnostics
Table 48. Global PCR and Real-time PCR Molecular Diagnostics Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 49. Global PCR and Real-time PCR Molecular Diagnostics Market Size Market Share Forecast by Regions (2025-2030)
Table 50. Global PCR and Real-time PCR Molecular Diagnostics Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 51. Global PCR and Real-time PCR Molecular Diagnostics Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 52. Abbott Laboratories Details, Company Type, PCR and Real-time PCR Molecular Diagnostics Area Served and Its Competitors
Table 53. Abbott Laboratories PCR and Real-time PCR Molecular Diagnostics Product Offered
Table 54. Abbott Laboratories PCR and Real-time PCR Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 55. Abbott Laboratories Main Business
Table 56. Abbott Laboratories Latest Developments
Table 57. bioMereieux SA Details, Company Type, PCR and Real-time PCR Molecular Diagnostics Area Served and Its Competitors
Table 58. bioMereieux SA PCR and Real-time PCR Molecular Diagnostics Product Offered
Table 59. bioMereieux SA Main Business
Table 60. bioMereieux SA PCR and Real-time PCR Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 61. bioMereieux SA Latest Developments
Table 62. Danaher Corporation Details, Company Type, PCR and Real-time PCR Molecular Diagnostics Area Served and Its Competitors
Table 63. Danaher Corporation PCR and Real-time PCR Molecular Diagnostics Product Offered
Table 64. Danaher Corporation Main Business
Table 65. Danaher Corporation PCR and Real-time PCR Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 66. Danaher Corporation Latest Developments
Table 67. Bio-Rad Laboratories Details, Company Type, PCR and Real-time PCR Molecular Diagnostics Area Served and Its Competitors
Table 68. Bio-Rad Laboratories PCR and Real-time PCR Molecular Diagnostics Product Offered
Table 69. Bio-Rad Laboratories Main Business
Table 70. Bio-Rad Laboratories PCR and Real-time PCR Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 71. Bio-Rad Laboratories Latest Developments
Table 72. QIAGEN N.V Details, Company Type, PCR and Real-time PCR Molecular Diagnostics Area Served and Its Competitors
Table 73. QIAGEN N.V PCR and Real-time PCR Molecular Diagnostics Product Offered
Table 74. QIAGEN N.V Main Business
Table 75. QIAGEN N.V PCR and Real-time PCR Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 76. QIAGEN N.V Latest Developments
Table 77. F-Hoffmann-La Roche Ltd. Details, Company Type, PCR and Real-time PCR Molecular Diagnostics Area Served and Its Competitors
Table 78. F-Hoffmann-La Roche Ltd. PCR and Real-time PCR Molecular Diagnostics Product Offered
Table 79. F-Hoffmann-La Roche Ltd. Main Business
Table 80. F-Hoffmann-La Roche Ltd. PCR and Real-time PCR Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 81. F-Hoffmann-La Roche Ltd. Latest Developments
Table 82. Genomic Health Details, Company Type, PCR and Real-time PCR Molecular Diagnostics Area Served and Its Competitors
Table 83. Genomic Health PCR and Real-time PCR Molecular Diagnostics Product Offered
Table 84. Genomic Health Main Business
Table 85. Genomic Health PCR and Real-time PCR Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 86. Genomic Health Latest Developments
Table 87. GRIFOLS S.A Details, Company Type, PCR and Real-time PCR Molecular Diagnostics Area Served and Its Competitors
Table 88. GRIFOLS S.A PCR and Real-time PCR Molecular Diagnostics Product Offered
Table 89. GRIFOLS S.A Main Business
Table 90. GRIFOLS S.A PCR and Real-time PCR Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 91. GRIFOLS S.A Latest Developments
Table 92. Thermo Fisher Scientific Inc. Details, Company Type, PCR and Real-time PCR Molecular Diagnostics Area Served and Its Competitors
Table 93. Thermo Fisher Scientific Inc. PCR and Real-time PCR Molecular Diagnostics Product Offered
Table 94. Thermo Fisher Scientific Inc. Main Business
Table 95. Thermo Fisher Scientific Inc. PCR and Real-time PCR Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 96. Thermo Fisher Scientific Inc. Latest Developments
Table 97. Seegene Inc. Details, Company Type, PCR and Real-time PCR Molecular Diagnostics Area Served and Its Competitors
Table 98. Seegene Inc. PCR and Real-time PCR Molecular Diagnostics Product Offered
Table 99. Seegene Inc. Main Business
Table 100. Seegene Inc. PCR and Real-time PCR Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 101. Seegene Inc. Latest Developments
Table 102. Hologic Inc. Details, Company Type, PCR and Real-time PCR Molecular Diagnostics Area Served and Its Competitors
Table 103. Hologic Inc. PCR and Real-time PCR Molecular Diagnostics Product Offered
Table 104. Hologic Inc. PCR and Real-time PCR Molecular Diagnostics Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 105. Hologic Inc. Main Business
Table 106. Hologic Inc. Latest Developments

LIST OF FIGURES

Figure 1. PCR and Real-time PCR Molecular Diagnostics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global PCR and Real-time PCR Molecular Diagnostics Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. PCR and Real-time PCR Molecular Diagnostics Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. PCR and Real-time PCR Molecular Diagnostics Sales Market Share by Country/Region (2023)
Figure 8. PCR and Real-time PCR Molecular Diagnostics Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Type in 2023
Figure 10. PCR and Real-time PCR Molecular Diagnostics in Infectious Diseases Testing
Figure 11. Global PCR and Real-time PCR Molecular Diagnostics Market: Infectious Diseases Testing (2019-2024) & ($ Millions)
Figure 12. PCR and Real-time PCR Molecular Diagnostics in Oncology Testing
Figure 13. Global PCR and Real-time PCR Molecular Diagnostics Market: Oncology Testing (2019-2024) & ($ Millions)
Figure 14. PCR and Real-time PCR Molecular Diagnostics in Genetic Testing
Figure 15. Global PCR and Real-time PCR Molecular Diagnostics Market: Genetic Testing (2019-2024) & ($ Millions)
Figure 16. PCR and Real-time PCR Molecular Diagnostics in Others
Figure 17. Global PCR and Real-time PCR Molecular Diagnostics Market: Others (2019-2024) & ($ Millions)
Figure 18. Global PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Application in 2023
Figure 19. Global PCR and Real-time PCR Molecular Diagnostics Revenue Market Share by Player in 2023
Figure 20. Global PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Regions (2019-2024)
Figure 21. Americas PCR and Real-time PCR Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 22. APAC PCR and Real-time PCR Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 23. Europe PCR and Real-time PCR Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size 2019-2024 ($ Millions)
Figure 25. Americas PCR and Real-time PCR Molecular Diagnostics Value Market Share by Country in 2023
Figure 26. United States PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Region in 2023
Figure 31. APAC PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Type in 2023
Figure 32. APAC PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Application in 2023
Figure 33. China PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 37. India PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Country in 2023
Figure 40. Europe PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Figure 41. Europe PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Figure 42. Germany PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 43. France PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size Market Share by Application (2019-2024)
Figure 50. Egypt PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country PCR and Real-time PCR Molecular Diagnostics Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 56. APAC PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 57. Europe PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 59. United States PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 60. Canada PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 61. Mexico PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 62. Brazil PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 63. China PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 64. Japan PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 65. Korea PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 67. India PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 68. Australia PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 69. Germany PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 70. France PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 71. UK PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 72. Italy PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 73. Russia PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 74. Spain PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 75. Egypt PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 76. South Africa PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 77. Israel PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 78. Turkey PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries PCR and Real-time PCR Molecular Diagnostics Market Size 2025-2030 ($ Millions)
Figure 80. Global PCR and Real-time PCR Molecular Diagnostics Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global PCR and Real-time PCR Molecular Diagnostics Market Size Market Share Forecast by Application (2025-2030)


More Publications